Escitalopram and Mesna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Escitalopram (escitalopram oxalate) and Mesna (mesna). Common drug interactions include diarrhoea among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Escitalopram and Mesna. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

What is Mesna?

Mesna has active ingredients of mesna. eHealthMe is studying from 9,647 Mesna users. Check the latest studies of Mesna.



On Jul, 16, 2026

40 people who take Escitalopram and Mesna together, and have interactions are studied.

Escitalopram and Mesna drug interactions.

What are the common drug interactions of Escitalopram and Mesna, by gender? *:

female:

  1. Diarrhoea
  2. Hyperbilirubinaemia (excess of bilirubin in the blood)
  3. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  4. Pyrexia (fever)
  5. Dyspnoea (difficult or laboured respiration)
  6. Encephalopathy (functioning of the brain is affected by some agent or condition)
  7. Hypervolaemia (abnormally increased volume of blood)
  8. Hypoxia (low oxygen in tissues)
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Alanine aminotransferase increased
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  7. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  8. Fall
  9. Hydrocephalus (water on the brain)
  10. Hypernatraemia (an abnormally high plasma concentration of sodium ions)

What are the common drug interactions of Escitalopram and Mesna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pleural effusion (water on the lungs)
  2. Respiratory distress (difficulty in breathing)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Alanine aminotransferase increased
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Hypoxia (low oxygen in tissues)
  7. Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  10. Diarrhoea

20-29:

n/a

30-39:

  1. Blood pressure increased
  2. Chest discomfort
  3. Chills (felling of cold)
  4. Cough
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. Heart rate increased
  8. Hypoxia (low oxygen in tissues)
  9. Nausea (feeling of having an urge to vomit)
  10. Oxygen saturation decreased

40-49:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Alopecia (absence of hair from areas of the body)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Back pain
  5. Blood disorder
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Decreased appetite
  9. Dehydration (dryness resulting from the removal of water)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

50-59:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

  1. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  2. Dyspnoea (difficult or laboured respiration)
  3. Distributive shock (hock caused by poor distribution of the blood flow)
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Hypervolaemia (abnormally increased volume of blood)
  7. Hypotension (abnormally low blood pressure)
  8. Hypoxia (low oxygen in tissues)
  9. Lethargy (tiredness)
  10. Lower respiratory tract infection

What are the existing conditions these people have? *

  1. Cytomegalovirus Infection: 10 people, 25.00%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 7 people, 17.50%
  3. Adenovirus Infection: 5 people, 12.50%
  4. Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 12.50%
  5. Pneumonia Fungal: 5 people, 12.50%
  6. Fungal Infection: 5 people, 12.50%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 12.50%
  8. High Blood Pressure: 4 people, 10.00%
  9. Pain: 4 people, 10.00%
  10. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and Mesna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Escitalopram and Mesna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Escitalopram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and mesna (the active ingredients of Escitalopram and Mesna, respectively), and Escitalopram and Mesna (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: